October sees a frenzy of biotech IPOs
October sees a frenzy of biotech IPOs October was the busiest month in three years for initial public offerings in the biotechnology sector. But the performance of the newly listed companies has been lacklustre as investors proved wary of betting on businesses that have yet to show a profit.